Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
12/1993
12/23/1993CA2138415A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof
12/23/1993CA2098876A1 2'-deoxy-2',2-'difluoro(2,6,8-substituted)purine nucleosides having anti-viral and anti-cancer activity and intermediates
12/23/1993CA2098875A1 2'-deoxy-2'-2'-difluoro(4-substituted pyrimidine)nucleosides having anti-viral and anti-cancer activity and intermediates
12/22/1993EP0574457A1 Antiviral nucleoside combination
12/21/1993US5272250 Boronated phosphoramidate compounds
12/21/1993US5272068 Process for producing immunosuppressant agent L-683942 by fermentation
12/21/1993CA1325423C Process for the synthesis of azido-3'-deoxy-3'-thiamidine and analogs
12/21/1993CA1325395C Macrolide compound
12/15/1993EP0573479A1 Chimeric tar enzyme construction for hiv therapy
12/15/1993CN1079473A N-phosphinylidyne small peptide
12/14/1993US5270304 Therapeutic 2-alkynyl adenosine agent for ischemic diseases of the heart or brain
12/14/1993US5270163 Methods for identifying nucleic acid ligands
12/14/1993CA1325209C Certain 2-substituted adenosine derivatives
12/14/1993CA1325208C Antiparasitic agents
12/14/1993CA1325207C Insecticides and parasiticides
12/09/1993WO1993024511A1 Oligonucleotide-polyamide conjugates
12/09/1993WO1993024510A1 Phosphotriester-type biologically active compounds
12/09/1993WO1993024508A1 Binding competent oligomers containing 2', 5' linkages
12/09/1993WO1993024507A1 Conformationally restrained oligomers containing amide or carbamate linkages for sequence-specific binding
12/09/1993WO1993024505A1 Reducing inflammation by time dependent administration of oligosaccharides glycosides related to blood group determinants
12/09/1993CA2118522A1 Time dependent administration of oligosaccharides glycosides related to blood group determinants having a type i or type ii core structure in reducing inflammation in a sensitizedmammal arising from exposure to an antigen
12/08/1993EP0572669A1 1-B(beta)-D-Arabinofuranosyl-(E)-5-(2-halogenovinyl)-uracil-derivative
12/08/1993EP0572644A1 DERIVATIVES OF 9-($g(b)-D-XYLOFURANNOSYL)ADENINE AND OF 1-($g(b)-D-XYLOFURANNOSYL)CYTOSINE, PREPARATION THEREOF AND APPLICATION IN THERAPEUTICS
12/08/1993CN1079215A Morpholinyl derivatives of doxorubicin and process for their preparation
12/07/1993US5268464 Process for the preparation of nucleosides
12/07/1993US5268376 Containing alkoxy substitution
12/07/1993US5268370 Microbial transformation product of L-679,934
12/02/1993DE4217679A1 New cyclic guanosine-3,5-phosphoro-thioate derivs. - useful as ligands in affinity chromatography or for treating e.g. thromboses,. asthma, hypertonia or arteriosclerosis
12/01/1993EP0571474A1 Orthomolecular method of treating sickle cell disease
11/1993
11/30/1993US5266692 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
11/25/1993WO1993023569A1 Method and reagent for inhibiting viral replication
11/25/1993WO1993023418A1 Purine derivatives
11/25/1993WO1993023417A1 Novel adenosine derivatives
11/25/1993WO1993023416A1 Chemical synthesis of 2',3'-dideoxynucleoside 5'-triphosphates
11/25/1993WO1993023415A1 CHEMICAL SYNTHESIS OF 2',3'-DIDEOXYNUCLEOSIDE 5'-(α-THIO) TRIPHOSPHATES
11/25/1993WO1993023414A1 A process for the preparation of ribonucleotide reductase inhibitors
11/25/1993WO1993023413A1 Synthesis of nucleotide monomers
11/25/1993WO1993023058A1 Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia
11/25/1993WO1993023056A1 Preventive or therapeutic agent for infectious diseases containing mizoribine as active ingredient
11/25/1993WO1993023031A1 Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response
11/25/1993WO1993017651A3 Antiviral nucleoside analogues, their production and use
11/25/1993CA2135646A1 Method and reagent for inhibiting viral replication
11/25/1993CA2135498A1 Synthesis of nucleotide monomers
11/25/1993CA2113547A1 Purine derivatives
11/25/1993CA2113546A1 Novel adenosine derivatives
11/24/1993EP0571087A1 Cleavable phosphoramidites
11/24/1993EP0570519A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/24/1993EP0570514A1 Methylene phosphonate nucleoside analogs and oligonucleotide analogs made therefrom
11/24/1993CN1022834C Macrolide compounds, their prepn. and use
11/23/1993US5264564 Oligonucleotide analogs with novel linkages
11/23/1993US5264562 Oligonucleotide analogs with novel linkages
11/23/1993US5264561 Method of manufacturing 2',3'-dideoxy-2',3'-didehydronucleosides
11/23/1993US5264431 Inhibitors for proteinkinase C
11/18/1993EP0430987B1 An amplification assay for hydrolase enzymes
11/16/1993US5262531 Reaction of adenine with alkali metal alcoholate or alkali metal hydroxide to form salt and reaction with 1-chloro-2-deoxy pentofuranose with protective groups
11/16/1993US5262425 α-mannosidase inhibitors
11/16/1993US5262400 Antiparasitic and anthelmintic
11/11/1993WO1993022328A1 Adenosine derivatives having a2 agonist activity
11/11/1993WO1993022327A1 2'-methylidenenucleoside compound and pharmaceutical use thereof
11/11/1993WO1993022326A1 Protecting groups useful in oligonucleotide synthesis
11/11/1993WO1993022325A1 Immunoassay for 3', 5' cyclic adenosine monophosphate
11/11/1993WO1993022307A1 Avermectin difluoro derivatives
11/11/1993CA2134067A1 Adenosine derivatives having a2 agonist activity
11/10/1993EP0569337A1 Heteroatoms-containing tricyclic compounds
11/10/1993EP0568946A1 Compound TAN-1607A, its derivatives, their production, and use thereof
11/10/1993EP0568553A1 Bridged cyclic ketal derivatives
11/10/1993CN1022688C Fluorocytidine derivatives
11/10/1993CN1022687C Process for prepn. of glycoside derivatives
11/09/1993US5260433 Saccharide specific binding system labeled nucleotides
11/09/1993US5260427 Nucleosidylphosphite-borane compounds and method of making the same
11/09/1993CA2095782A1 Compound tan-1607a, its derivatives, their production and use thereof
11/09/1993CA1324128C 2', 2'-difluoronucleosides
11/03/1993EP0567841A2 Fluorescently marked compounds, their preparation and use
11/03/1993EP0505388A4 Improved one piece pouring spout sealed to innermost and outermost surfaces of moisture impervious carton
10/1993
10/28/1993WO1993021201A1 Composition and method for utilizing nucleosides as ion carriers
10/28/1993WO1993020825A1 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
10/28/1993WO1993020805A1 Chemical prevention or reversal of cataract by phase separation inhibitors
10/28/1993CA2133727A1 Chemical prevention or reversal of cataract by phase separation inhibitors
10/27/1993EP0567094A2 Hydrazoadenosines
10/27/1993EP0566625A1 Method for extraction of intracellular components.
10/27/1993EP0432183B1 New citydin-5'-diphosphate alkanols and glycerols, a process for preparing them and their use
10/27/1993EP0271552B1 Derivatives of all-trans- and 13-cis retinoic acid and methods for preparing same
10/27/1993EP0222889B1 Cytidine analogs
10/27/1993EP0191824B1 Encapsulation of antineoplastic agents in liposomes
10/27/1993EP0190315B1 Dehydrated liposomes
10/27/1993CN1022570C Process for preparing antiviral compounds
10/26/1993US5256689 Cholesterol lowering compounds
10/26/1993US5256650 Hypotensive, antispasmodic agents; sedatives; vasodilation
10/26/1993US5256646 Antiviral antibiotic BU-4224V
10/26/1993US5256641 Covalent polar lipid-peptide conjugates for immunological targeting
10/20/1993EP0566459A1 Reagent and catalytic process for cleaving protected functional groups
10/20/1993EP0566162A1 2'-Methylidenepyrimidine Nucleoside Compounds, their use and method for production thereof
10/20/1993EP0565646A1 Nucleosides and oligonucleosides with a phosphate-free internucleoside backbone and process for preparing the same
10/20/1993EP0338042B1 Composition and method for treating hepatitis virus infections using 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil
10/19/1993US5254562 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
10/19/1993US5254539 Method of treating HIV with 2',3'-dideoxyinosine
10/16/1993CA2093989A1 Reagent and catalytic process for clearing a protected function
10/14/1993WO1993019762A1 Compositions for the treatment of infection and disease caused by hepatitis b virus (hbv)
10/14/1993WO1992008456A3 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated
10/13/1993EP0565412A1 Compositions containing 5-iodouracil derivatives for the treatment of hepatitis B infections